Assembly Biosciences, Inc. (ASMB) Total assets 2016–2025
Assembly Biosciences, Inc. (ASMB) total assets at each fiscal year-end, per SEC filings.
$257.6MFY2025 · since FY2016: $98.1M → $257.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $257.6M | +116.2% |
| FY2024 | $119.2M | -12.9% |
| FY2023 | $136.8M | +34.4% |
| FY2022 | $101.8M | -46.7% |
| FY2021 | $191.1M | -32.5% |
| FY2020 | $283.3M | -16.7% |
| FY2019 | $339.9M | +26.8% |
| FY2018 | $268.0M | +58.3% |
| FY2017 | $169.3M | +72.6% |
| FY2016 | $98.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ASMB financial trends
ASMB RevenueASMB Net incomeASMB Net marginASMB Gross profitASMB Gross marginASMB Operating incomeASMB Operating marginASMB Operating cash flowASMB Free cash flowASMB Capital expendituresASMB Return on equityASMB Stock buybacksASMB Dividends paidASMB Total liabilitiesASMB Shareholders’ equityASMB overview →